Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients With Early Stage Cancer of the Endometrium

NCT01686126 is registered in ClinicalTrials.gov with Queensland Centre for Gynaecological Cancer as lead sponsor.

NCT NCT01686126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01686126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients With Early Stage Cancer of the Endometrium
Lead sponsor
Queensland Centre for Gynaecological Cancer
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 31, 2012
Completion date
December 31, 2026
Enrollment
165 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

complex endometrial hyperplasia with atypia, grade 1 endometrial endometrioid adenocarcinoma